Properties of dimeric, disulfide-linked rhBMP-2 recovered from E. coli derived inclusion bodies by mild extraction or chaotropic solubilization and subsequent refolding

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

  • Bastian Quaas
  • Laura Burmeister
  • Zhaopeng Li
  • Manfred Nimtz
  • Andrea Hoffmann
  • Ursula Rinas

Organisationseinheiten

Externe Organisationen

  • Medizinische Hochschule Hannover (MHH)
  • Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
  • NIFE- Niedersächsisches Zentrum für Biomedizintechnik, Implantatforschung und Entwicklung
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)80-87
Seitenumfang8
FachzeitschriftProcess Biochemistry
Jahrgang67
Frühes Online-Datum5 Feb. 2018
PublikationsstatusVeröffentlicht - Apr. 2018

Abstract

Recombinant human bone morphogenetic protein-2 (rhBMP-2), a cystine-knot containing disulfide-linked homodimer, was produced in form of inclusion bodies (IBs) using E. coli BL21 (DE3) and SHuffle T7 Express. Non-reducing SDS-PAGE analysis revealed that rhBMP-2 was present within IBs in both strains as monomer and in form of disulfide-linked dimers. Purified dimeric disulfide-linked rhBMP-2 was obtained from IBs by two different methods. The first method involved classical solubilization using strong denaturants and subsequent refolding. The second method involved mild extraction without refolding. Both rhBMP-2 dimer variants were purified by Heparin-affinity chromatography. Mildly extracted rhBMP-2 was further purified by size-exclusion chromatography. The resulting dimeric rhBMP-2 variants were studied regarding bioactivity and folding status. In contrast to the rhBMP-2 dimer obtained by classical refolding it was shown that the disulfide-linked dimer obtained by mild extraction was not correctly folded e.g. the hydrophobic core not correctly formed. Moreover, refolded dimeric rhBMP-2 was bioactive and the mildly extracted dimeric rhBMP-2 did not show any bioactivity. Disulfide-bond analysis revealed that the intricate disulfide-bond pattern of the complex cystine-knot scaffold was not present in the IB embedded disulfide-linked rhBMP-2 dimer but was formed later during classical refolding of the reduced protein under appropriate redox conditions.

ASJC Scopus Sachgebiete

Zitieren

Properties of dimeric, disulfide-linked rhBMP-2 recovered from E. coli derived inclusion bodies by mild extraction or chaotropic solubilization and subsequent refolding. / Quaas, Bastian; Burmeister, Laura; Li, Zhaopeng et al.
in: Process Biochemistry, Jahrgang 67, 04.2018, S. 80-87.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Quaas B, Burmeister L, Li Z, Nimtz M, Hoffmann A, Rinas U. Properties of dimeric, disulfide-linked rhBMP-2 recovered from E. coli derived inclusion bodies by mild extraction or chaotropic solubilization and subsequent refolding. Process Biochemistry. 2018 Apr;67:80-87. Epub 2018 Feb 5. doi: 10.1016/j.procbio.2018.02.001
Download
@article{ec34971e4ea04d6a8cdb722f76f3847c,
title = "Properties of dimeric, disulfide-linked rhBMP-2 recovered from E. coli derived inclusion bodies by mild extraction or chaotropic solubilization and subsequent refolding",
abstract = "Recombinant human bone morphogenetic protein-2 (rhBMP-2), a cystine-knot containing disulfide-linked homodimer, was produced in form of inclusion bodies (IBs) using E. coli BL21 (DE3) and SHuffle T7 Express. Non-reducing SDS-PAGE analysis revealed that rhBMP-2 was present within IBs in both strains as monomer and in form of disulfide-linked dimers. Purified dimeric disulfide-linked rhBMP-2 was obtained from IBs by two different methods. The first method involved classical solubilization using strong denaturants and subsequent refolding. The second method involved mild extraction without refolding. Both rhBMP-2 dimer variants were purified by Heparin-affinity chromatography. Mildly extracted rhBMP-2 was further purified by size-exclusion chromatography. The resulting dimeric rhBMP-2 variants were studied regarding bioactivity and folding status. In contrast to the rhBMP-2 dimer obtained by classical refolding it was shown that the disulfide-linked dimer obtained by mild extraction was not correctly folded e.g. the hydrophobic core not correctly formed. Moreover, refolded dimeric rhBMP-2 was bioactive and the mildly extracted dimeric rhBMP-2 did not show any bioactivity. Disulfide-bond analysis revealed that the intricate disulfide-bond pattern of the complex cystine-knot scaffold was not present in the IB embedded disulfide-linked rhBMP-2 dimer but was formed later during classical refolding of the reduced protein under appropriate redox conditions.",
keywords = "BRE-Luc assay, Cystine-knot, Disulfide-bond, Heparin-affinity chromatography, Mild extraction, Purification, Recombinant human bone morphogenetic protein-2, Refolding",
author = "Bastian Quaas and Laura Burmeister and Zhaopeng Li and Manfred Nimtz and Andrea Hoffmann and Ursula Rinas",
note = "Funding Information: The authors gratefully acknowledge funding through the Forschergruppe “Gradierte Implantate” FOR2180 and the Exzellenzcluster “Rebirth” EXC62 , both Deutsche Forschungsgemeinschaft (DFG). In addition, the authors acknowledge Thilo Fl{\"o}rkemeier, Department of Orthopaedic Surgery (Annastift), for providing bone marrow for isolation of the human mesenchymal stem cells. ",
year = "2018",
month = apr,
doi = "10.1016/j.procbio.2018.02.001",
language = "English",
volume = "67",
pages = "80--87",
journal = "Process Biochemistry",
issn = "1359-5113",
publisher = "Elsevier BV",

}

Download

TY - JOUR

T1 - Properties of dimeric, disulfide-linked rhBMP-2 recovered from E. coli derived inclusion bodies by mild extraction or chaotropic solubilization and subsequent refolding

AU - Quaas, Bastian

AU - Burmeister, Laura

AU - Li, Zhaopeng

AU - Nimtz, Manfred

AU - Hoffmann, Andrea

AU - Rinas, Ursula

N1 - Funding Information: The authors gratefully acknowledge funding through the Forschergruppe “Gradierte Implantate” FOR2180 and the Exzellenzcluster “Rebirth” EXC62 , both Deutsche Forschungsgemeinschaft (DFG). In addition, the authors acknowledge Thilo Flörkemeier, Department of Orthopaedic Surgery (Annastift), for providing bone marrow for isolation of the human mesenchymal stem cells.

PY - 2018/4

Y1 - 2018/4

N2 - Recombinant human bone morphogenetic protein-2 (rhBMP-2), a cystine-knot containing disulfide-linked homodimer, was produced in form of inclusion bodies (IBs) using E. coli BL21 (DE3) and SHuffle T7 Express. Non-reducing SDS-PAGE analysis revealed that rhBMP-2 was present within IBs in both strains as monomer and in form of disulfide-linked dimers. Purified dimeric disulfide-linked rhBMP-2 was obtained from IBs by two different methods. The first method involved classical solubilization using strong denaturants and subsequent refolding. The second method involved mild extraction without refolding. Both rhBMP-2 dimer variants were purified by Heparin-affinity chromatography. Mildly extracted rhBMP-2 was further purified by size-exclusion chromatography. The resulting dimeric rhBMP-2 variants were studied regarding bioactivity and folding status. In contrast to the rhBMP-2 dimer obtained by classical refolding it was shown that the disulfide-linked dimer obtained by mild extraction was not correctly folded e.g. the hydrophobic core not correctly formed. Moreover, refolded dimeric rhBMP-2 was bioactive and the mildly extracted dimeric rhBMP-2 did not show any bioactivity. Disulfide-bond analysis revealed that the intricate disulfide-bond pattern of the complex cystine-knot scaffold was not present in the IB embedded disulfide-linked rhBMP-2 dimer but was formed later during classical refolding of the reduced protein under appropriate redox conditions.

AB - Recombinant human bone morphogenetic protein-2 (rhBMP-2), a cystine-knot containing disulfide-linked homodimer, was produced in form of inclusion bodies (IBs) using E. coli BL21 (DE3) and SHuffle T7 Express. Non-reducing SDS-PAGE analysis revealed that rhBMP-2 was present within IBs in both strains as monomer and in form of disulfide-linked dimers. Purified dimeric disulfide-linked rhBMP-2 was obtained from IBs by two different methods. The first method involved classical solubilization using strong denaturants and subsequent refolding. The second method involved mild extraction without refolding. Both rhBMP-2 dimer variants were purified by Heparin-affinity chromatography. Mildly extracted rhBMP-2 was further purified by size-exclusion chromatography. The resulting dimeric rhBMP-2 variants were studied regarding bioactivity and folding status. In contrast to the rhBMP-2 dimer obtained by classical refolding it was shown that the disulfide-linked dimer obtained by mild extraction was not correctly folded e.g. the hydrophobic core not correctly formed. Moreover, refolded dimeric rhBMP-2 was bioactive and the mildly extracted dimeric rhBMP-2 did not show any bioactivity. Disulfide-bond analysis revealed that the intricate disulfide-bond pattern of the complex cystine-knot scaffold was not present in the IB embedded disulfide-linked rhBMP-2 dimer but was formed later during classical refolding of the reduced protein under appropriate redox conditions.

KW - BRE-Luc assay

KW - Cystine-knot

KW - Disulfide-bond

KW - Heparin-affinity chromatography

KW - Mild extraction

KW - Purification

KW - Recombinant human bone morphogenetic protein-2

KW - Refolding

UR - http://www.scopus.com/inward/record.url?scp=85044017732&partnerID=8YFLogxK

U2 - 10.1016/j.procbio.2018.02.001

DO - 10.1016/j.procbio.2018.02.001

M3 - Article

AN - SCOPUS:85044017732

VL - 67

SP - 80

EP - 87

JO - Process Biochemistry

JF - Process Biochemistry

SN - 1359-5113

ER -